Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)

Author： Bamias A.   Dafni U.   Karadimou A.   Timotheadou E.   Aravantinos G.   Psyrri A.   Xanthakis I.   Tsiatas M.   Koutoulidis V.   Constantinidis C.   Hatzimouratidis C.   Samantas E.   Visvikis A.   Chrisophos M.   Stravodimos K.   Deliveliotis C.   Eleftheraki A.   Pectasides D.   Fountzilas G.   Dimopoulos M. A.  

Publisher： Oxford University Press

ISSN： 0923-7534

Source： Annals of Oncology, Vol.24, Iss.4, 2013-04, pp. : 1011-1017

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gemcitabine Combined with Gefitinib in Patients with Inoperable or Metastatic Pancreatic Cancer: A Phase II Study of the Hellenic Cooperative Oncology Group with Biomarker Evaluation

By Fountzilas George   Bobos Mattheos   Kalogera-Fountzila Anna   Xiros Nikolaos   Murray Samuel   Linardou Helena   Karayannopoulou Georgia   Koutras Angelos   Bafaloukos Dimitrios   Samantas Epaminondas   Christodoulou Christos   Economopoulos Theofanis   Kalogeras Konstantine   Kosmidis Paris  

Cancer Investigation, Vol. 26, Iss. 8, 2008-10 ,pp. : 784-793

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant Dose-Dense Sequential Chemotherapy with Epirubicin, CMF and Weekly Paclitaxel in Patients with Resected High-Risk Breast Cancer: A Hellenic Cooperative Oncology Group (HeCOG) Study

By Papadimitriou Christos   Papakostas Pavlos   Timotheadou Eleni   Aravantinos Gerasimos   Bamias Aristotelis   Fountzilas George  

Cancer Investigation, Vol. 26, Iss. 5, 2008-06 ,pp. : 491-498

Informa Healthcare

Access to resources Recommend Favorite

Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer: A hellenic cooperative oncology group phase III study

By Fountzilas George   Ciuleanu Elisabeta   Dafni Urania   Plataniotis George   Kalogera-Fountzila Anna   Samantas Epaminontas   Athanassiou Eleni   Tzitzikas John   Ciuleanu Tudor   Nikolaou Angelos   Pantelakos Panayiotis   Zaraboukas Thomas   Zamboglou Nikolaos   Daniilidis John   Ghilezan Nicolas  

Medical Oncology, Vol. 21, Iss. 2, 2004-06 ,pp. : 95-107

Humana Press, Inc

Access to resources Recommend Favorite

Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study

By Christodoulou Christos   Bafaloukos Dimitrios   Linardou Helen   Aravantinos Gerassimos   Bamias Aristotelis   Carina Maria   Klouvas George   Skarlos Dimosthenis  

Journal of Neuro-Oncology, Vol. 71, Iss. 1, 2005-01 ,pp. : 61-65

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer

By Cooper Brenda   Radivoyevitch Tomas   Overmoyer Beth   Shenk Robert   Pham Huong   Samuels Judith   Parry Margaret   Silverman Paula  

Breast Cancer Research and Treatment, Vol. 97, Iss. 3, 2006-06 ,pp. : 311-318

Springer Publishing Company

Access to resources Recommend Favorite